SANDEEP BHOGILAL SHAH

      DIN: 02350692

      For latest information about the director, visit MCA.

      SANDEEP BHOGILAL SHAH is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 02350692. SANDEEP BHOGILAL SHAH is/has been associated with 20 companies.

      This is just one Director. Want to discover lot more?

      Unlock deeper insights with Prime Research AI

      Companies Associated With

      Company Designation Date of Appointment
      RUBY DIAGNOCARE LLP Designated Partner 10-Apr-2013
      KONDHWA DIAGNOSTICS CENTRE LLP Designated Partner 08-Jun-2016
      MIRAJ NUCLEAR MEDICINE AND MOLECULAR IMA GING CENTER LLP Partner 29-Mar-2017
      AADHAR MULTI-SPECIALITY HOSPITAL LLP Partner 17-Aug-2017
      PANDHARPUR SUPER SPECIALITY HOSPITAL & R ESEARCH CENTER LLP Partner 25-Oct-2017
      WAY 2 HEALTH EXPRESS LLP Designated Partner 16-Jan-2020
      THINK TANK BIZSERVE LLP Designated Partner 13-Feb-2020
      RUBYSTAR AILCARE SERVICES LLP Partner 12-Oct-2021
      SHREE SWAMI SAMARTH MULTISPECIALITY HOSP ITAL LLP Designated Partner 25-Nov-2021
      ISLAMPUR MULTISPECIALITY HOSPITAL LLP Partner 12-Jan-2022
      DAKSHATA RUGNALAYA LLP Designated Partner 16-Nov-2022
      CREATIVE REMEDIES PVT LTD Director 11-Apr-2005
      LATUR MEDICHEM PRIVATE LIMITED Additional Director 22-Nov-2021
      SONIKA CORPORATION PRIVATE LIMITED Director 30-Sep-2016
      UNI-MEDICAL SERVICES PRIVATE LIMITED Director 14-Nov-2013
      RUBY AILCARE SERVICES PRIVATE LIMITED Director 30-Jun-2005

      Past Companies Associated With

      Company Designation Date of Appointment Date of Cessation
      SONIKA CORPORATION PRIVATE LIMITED Additional Director 24-Nov-2015 30-Sep-2016
      HEALTH EXPRESS DIAGNOSTICS PRIVATE LIMITED Additional Director 06-Jan-2020 31-Dec-2020
      HEALTH EXPRESS DIAGNOSTICS PRIVATE LIMITED Director 31-Dec-2020 10-Sep-2021
      HEALTH AND HYGIENE WASTE MANAGEMENT SOLUTIONS PRIVATE LIMITED Director 16-Aug-2010 23-Mar-2022

      “Assess financial performance of all companies under a director.”

      Explore Prime Research Explore for Sales